SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (10444)7/4/1998 1:46:00 PM
From: blankmind  Respond to of 23519
 
Thanks - & here's the words I've been waitingn for so long:

"A year ago, approximately 80 percent of Muse sales came from this country and 20 percent came from abroad. Those figures are now reversed. Vivus has received approval to sell Muse in nine countries and expects to win approval in 20 more by the end of this year, Levitt said."


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News